2 results match your criteria: "Haydarpasa Educational and Research Hospital[Affiliation]"
Does early PET/CT assesment of response to chemotherapy predicts survival in patients with advanced stage non-small-cell lung cancer?
Medicine (Baltimore)
December 2014
From the Department of Medical Oncology, Bilim University, Istanbul, Turkey (CO, KP); Department of Nuclear Medicine, Yeditepe University, Istanbul, Turkey (NAS); Department of Nuclear Medicine, Bezmi Alem Foundation University, Istanbul, Turkey (EE); Department of Radiation Oncology, Balikesir State Hospital, Balikesir, Turkey (GA); Department of Radiation Oncology, Bezmi Alem Foundation University, Istanbul, Turkey (ZG); Department of Nuclear Medicine, Balikesir State Hospital, Balikesir, Turkey (HM, SD); and Department of Radiology, Haydarpasa Educational and Research Hospital, Istanbul, Turkey (EY).
The aim of this study is to determine the prognostic role and the timing of metabolic response to chemotherapy, based on F-fluorodeoxyglucose positron emission tomography (F-FDG-PET), in patients with metastatic non-small-cell lung cancer (NSCLC). The study included 55 patients with metastatic NSCLC that were analyzed in terms of prognostic factors and survival. F-FDG-PET/CT findings were evaluated in patients separated into 3 groups, before and after 1st, 2nd, 3rd cycle of the first line chemotherapy.
View Article and Find Full Text PDFTransmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey.
J Int AIDS Soc
January 2016
Infectious Diseases, Kocaeli University, Kocaeli, Turkey.
Introduction: The objective of this study was to determine the transmitted drug resistance mutations (TDRMs) in newly diagnosed HIV-1 positive patients in Turkey.
Materials And Methods: The study was carried out between 2009 and 2014 and antiretroviral naïve 774 HIV-1 infected patients from 19 Infectious Diseases and Clinical Microbiology Departments in Turkey were included; gender: 664 (86%) male, median age: 37 (range; 1-77), median CD4+T-cell: 360 (range; 1-1320) count/mm(3), median HIV-RNA load: 2.10+E6 (range; 4.